Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
Psychiatry Research. Neuroimaging|March 23, 2023
Discrimination of auditory verbal hallucination in schizophrenia based on EEG brain networksJiuju Wang, Wentian Dong, Yuqin Li, et al.
Blood Advances|February 4, 2026
A specific FX activator for bleeding treatment in hemophilia with inhibitors: multicenter, open-label, phase I/II trialsWei Liu, Hu Zhou, Ruibin Huang, et al.
Frontiers in Medicine|January 24, 2022
Factors Associated With the Presence of Foveal Bulge in Eyes With Resolved Diabetic Macular EdemaQiaowei Wu, Yijun Hu, Baoyi Liu, et al.
Heliyon|February 9, 2024
The prognostic significance and clinical relevance of stem cell characteristic in bladder cancerXia Chen, Yuanyuan Yin, Yuming He, et al.
Journal of Affective Disorders|January 6, 2025
Heart rate variability in subthreshold depression and major depressive disorderYinliang Tan, Meihong Zhou, Jiuju Wang, et al.
Medical Physics|July 8, 2024
Machine learning-based CT radiomics enhances bladder cancer staging predictions: A comparative study of clinical, radiomics, and combined modelsSitu Xiong, Zhehong Fu, Zhikang Deng, et al.
Eclinicalmedicine|September 2, 2025
Dose-optimised recombinant human thrombopoietin <i>versus</i> eltrombopag in patients with immune thrombocytopenia: a multicenter, randomised controlled trial (The TE-ITP Study)Yunfei Chen, Ting Sun, Da Gao, et al.
Acta Ophthalmologica|November 27, 2023
Safety and efficacy of intravitreal injection of conbercept for the treatment of patients with choroidal neovascularization secondary to pathological myopia: Results from the SHINY studyLiqin Gao, Yanping Song, Xiaodong Sun, et al.
Cell|August 21, 2010
Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survivalXiaolan Zhou, Jin Lin Wang, John Lu, et al.
The Lancet Regional Health. Western Pacific|May 29, 2024
Zuberitamab, an innovative anti-CD20 monoclonal antibody, for patients with primary immune thrombocytopenia in China: a randomized, double-blind, placebo-controlled, phase 2 studyMin Xu, Jinhui Shu, Shenxian Qian, et al.
Pageof 15